An in vitro study on the interaction of the anti-Alzheimer drug rivastigmine with human erythrocytes

Chem Biol Interact. 2020 Mar 1:319:109019. doi: 10.1016/j.cbi.2020.109019. Epub 2020 Feb 21.

Abstract

The inhibition of the enzyme acetylcholinesterase (AChE) is a frequently used therapeutic option to treat Alzheimer's disease (AD). By decreasing the levels of acetylcholine degradation in the synaptic space, some cognitive functions of patients suffering from this disease are significantly improved. Rivastigmine is one of the most widely used AChE inhibitors. The objective of this work was to determine the effects of this drug on human erythrocytes, which have a type of AChE in the cell membrane. To that end, human erythrocytes and molecular models of its membrane constituted by dimyristoylphosphatidylcholine (DMPC) and dimyristoylphosphatidylethanolamine (DMPE) were used. They correspond to classes of phospholipids present in the outer and inner monolayers of the human erythrocyte membrane, respectively. The experimental results obtained by X-ray diffraction and differential scanning calorimetry (DSC) indicated that rivastigmine molecules were able to interact with both phospholipids. Fluorescence spectroscopy results showed that rivastigmine produce a slight change in the acyl chain packing order and a weak displacement of the water molecules of the hydrophobic-hydrophilic membrane interface. On the other hand, observations by scanning electron microscopy (SEM) showed that the drug changed the normal biconcave shape of erythrocytes in stomatocytes (cup-shaped cells) and echinocytes (speculated shaped).

Keywords: Acethylcholinesterase; Cell membrane; Human erythrocyte; Lipid bilayer; Rivastigmine.

MeSH terms

  • Acetylcholinesterase / metabolism
  • Alzheimer Disease / drug therapy*
  • Alzheimer Disease / metabolism
  • Calorimetry, Differential Scanning / methods
  • Cell Shape / drug effects
  • Cholinesterase Inhibitors / pharmacology*
  • Dimyristoylphosphatidylcholine / metabolism
  • Erythrocyte Membrane / drug effects
  • Erythrocyte Membrane / metabolism
  • Erythrocytes / drug effects*
  • Erythrocytes / metabolism
  • Humans
  • Microscopy, Electron, Scanning / methods
  • Models, Molecular
  • Phosphatidylethanolamines / metabolism
  • Phospholipids / metabolism
  • Rivastigmine / pharmacology*
  • Spectrometry, Fluorescence / methods
  • X-Ray Diffraction / methods

Substances

  • Cholinesterase Inhibitors
  • Phosphatidylethanolamines
  • Phospholipids
  • Acetylcholinesterase
  • Rivastigmine
  • Dimyristoylphosphatidylcholine
  • 1,2-dimyristoylphosphatidylethanolamine